Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of the nighttime effects of rabeprazole 20 mg to pantoprazole 40 mg on standard meal stimulated gastric acid secretion and intragastric pH in H. pylori [helicobacter pylori] negative volunteer subjects with GERD [gastro-oesophageal reflux]

Next Previous
Trial Profile

Comparison of the nighttime effects of rabeprazole 20 mg to pantoprazole 40 mg on standard meal stimulated gastric acid secretion and intragastric pH in H. pylori [helicobacter pylori] negative volunteer subjects with GERD [gastro-oesophageal reflux]

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2007

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pantoprazole (Primary) ; Rabeprazole (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacodynamics

Most Recent Events

  • 14 Sep 2007 Status change
  • 15 Oct 2006 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top